Anthropic announced a Claude-led discovery of a molecular machine that may represent a new gene editing mechanism, emphasizing AI's potential to rapidly advance biological research from weak to superhuman levels.
Today we announced the Claude-led discovery of a molecular machine that we suspect could represent a new gene editing mechanism. Its precise function, biotechnological utility (if any), or level of significance is not yet clear, but at minimum it is work I would have been proud to do as a PhD student. The work was done mostly, though not entirely, by Claude: our life sciences team suggested a broad area of research, Claude read through the literature and a bunch of genome data and discovered something interesting, then Claude proposed experiments to verify the discovery and our team carried them out. It’s easy to dismiss this as a one-off or curiosity, but we’ve repeatedly seen a pattern where AI performance in new intellectual domains goes from weak to superhuman in a matter of a few years. In 2023 models struggled to do math at the level of an average high-school student. In 2024 they started to do well on math competitions for the best high-schoolers in the country, in 2025 they started to solve minor open problems, in early 2026 more significant open problems, and in late 2026 they are beginning to solve the top few open problems in all of mathematics. We believe AI for biology is on a similar exponential trend. As we’ve demonstrated today, humans can collaborate with AI to perform the experiments, validate key results in a few weeks and, if necessary, work with the AI to iterate on what they find. Improving our understanding of biology and sharpening biologists’ tools can drive forward all of the later stages, for example by identifying new drug targets, finding new therapeutic modalities, allowing for more precise measurement, and speeding up the experimental loop which itself further accelerates our understanding of biology. In Machines of Loving Grace, I wrote about AI’s potential to “cure most diseases in 5-10 years” — a goal that sounds impossible, but one I believe is just barely possible if AI is applied to every stage of the pipeline. The first step is showing that AI can first help with, and then drive, biological discoveries. https://x.com/DarioAmodei/status/2102831170299834652
Anthropic's biology lab, using its AI model Claude, discovered a novel enzyme system in bacteriophage DNA with properties reminiscent of CRISPR, potentially advancing gene-editing technology.
Anthropic's AI Claude autonomously discovered a new enzyme system similar to Crispr in its biolab, demonstrating AI's capabilities for scientific research.
Anthropic used 950 Claude agents for 21 hours to find a candidate protein for gene editing, potentially a new CRISPR-like mechanism, highlighting the rapid advancement of AI in scientific research.
Dario Amodei, CEO of Anthropic, argues that AI could cure most human diseases within 5-10 years and stresses the need for real results to address public trust issues in AI.